Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-70,915
Closed -$3.92M 404
2018
Q2
$3.92M Sell
70,915
-14,285
-17% -$660K 0.16% 220
2018
Q1
$3.24M Sell
85,200
-50
-0.1% -$1.55K 0.14% 222
2017
Q4
$2.39M Sell
85,250
-3,325
-4% -$101K 0.1% 249
2017
Q3
$2.75M Buy
+88,575
New +$2.41M 0.11% 275

Other funds holding SRDX

Foundry Partners's SRDX Position: Q3 2018 in Review

Foundry Partners sold out of Surmodics (SRDX) in Q3 2018, closing a stake of 70,915 shares — an estimated $3.92M sold.

Foundry Partners first reported a position in SRDX in Q3 2017 and held it in 4 quarters. The position peaked at $3.92M in Q2 2018. 168 funds tracked by Wall St. Rank hold SRDX as of Q3 2018.

  • Foundry Partners reported no remaining Surmodics position as of Q3 2018 after selling out during the quarter.
  • Foundry Partners sold 70,915 Surmodics shares in Q3 2018, an estimated $3.92M.
  • Foundry Partners first reported a position in Surmodics in Q3 2017 and held it in 4 quarters.
  • Foundry Partners's Surmodics position peaked at $3.92M in Q2 2018.
  • 168 funds tracked by Wall St. Rank held Surmodics as of Q3 2018.

Based on Foundry Partners's 13F filing for Q3 2018, filed 17 Oct 2018.